Free Trial

Agilent Technologies (A) Stock Forecast & Price Target

Agilent Technologies logo
$102.38 -0.32 (-0.31%)
Closing price 04/17/2025 03:59 PM Eastern
Extended Trading
$102.48 +0.10 (+0.10%)
As of 04/17/2025 06:03 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Agilent Technologies - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
7
Buy
6

Based on 13 Wall Street analysts who have issued ratings for Agilent Technologies in the last 12 months, the stock has a consensus rating of "Hold." Out of the 13 analysts, 7 have given a hold rating, and 6 have given a buy rating for A.

Consensus Price Target

$144.58
41.22% Upside
According to the 13 analysts' twelve-month price targets for Agilent Technologies, the average price target is $144.58. The highest price target for A is $165.00, while the lowest price target for A is $115.00. The average price target represents a forecasted upside of 41.22% from the current price of $102.38.
Get the Latest News and Ratings for A and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Agilent Technologies and its competitors.

Sign Up

A Analyst Ratings Over Time

TypeCurrent Forecast
4/20/24 to 4/20/25
1 Month Ago
3/21/24 to 3/21/25
3 Months Ago
1/21/24 to 1/20/25
1 Year Ago
4/21/23 to 4/20/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
6 Buy rating(s)
7 Buy rating(s)
7 Buy rating(s)
11 Buy rating(s)
Hold
7 Hold rating(s)
7 Hold rating(s)
6 Hold rating(s)
5 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$144.58$146.15$143.62$141.29
Forecasted Upside41.22% Upside21.07% Upside-2.68% Downside6.45% Upside
Consensus Rating
Hold
Moderate Buy
Hold
Moderate Buy

A Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

A Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Agilent Technologies Stock vs. The Competition

TypeAgilent TechnologiesMedical CompaniesS&P 500
Consensus Rating Score
2.46
2.81
2.54
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside41.22% Upside21,675.79% Upside26.48% Upside
News Sentiment Rating
Positive News

See Recent A News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
4/17/2025Wells Fargo & Company
3 of 5 stars
Brandon Couillard
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOverweight ➝ Overweight$155.00 ➝ $135.00+31.59%
4/10/2025TD Cowen
4 of 5 stars
 Boost TargetBuy$135.00+36.23%
4/10/2025Barclays
3 of 5 stars
L. Sergott
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetEqual Weight ➝ Equal Weight$138.00 ➝ $115.00+14.25%
2/27/2025Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Catherine Schulte
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOutperform ➝ Outperform$161.00 ➝ $159.00+18.21%
12/19/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
P. Donnelly
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy$165.00+23.96%
12/13/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$153.00 ➝ $150.00+8.93%
11/26/2024Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetMarket Perform ➝ Market Perform$140.00 ➝ $135.00+1.41%
11/26/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight$165.00 ➝ $160.00+22.14%
10/1/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetIn-Line ➝ In-Line$135.00 ➝ $145.00-0.46%
8/26/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy$151.00+7.19%
8/22/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$141.00 ➝ $150.00+6.47%
6/27/2024Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
D. Schenkel
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Peer Perform
6/3/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Hold$152.00 ➝ $135.00+3.78%
3/26/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$67.00 ➝ $90.00-38.30%
12/7/2023The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$128.00 ➝ $145.00+12.47%
8/16/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$160.00 ➝ $150.00+19.38%
5/24/2023888
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMaintains
5/24/202358.com
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMaintains
5/24/2023SVB Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$170.00 ➝ $145.00+12.72%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 11:50 AM ET.


Should I Buy Agilent Technologies Stock? A Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, April 14, 2025. Please send any questions or comments about these Agilent Technologies pros and cons to contact@marketbeat.com.

Agilent Technologies
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Agilent Technologies, Inc.:

  • Agilent Technologies, Inc. recently reported earnings per share (EPS) of $1.31, exceeding analysts' expectations of $1.27, indicating strong financial performance and effective management.
  • The stock price has shown resilience, currently trading at $105.19, reflecting a 2.4% increase during recent trading hours, which may attract investors looking for growth potential.
  • Institutional investors hold a significant 87.42% of the stock, suggesting strong confidence in the company's future prospects and stability.
  • Agilent Technologies, Inc. has a solid return on equity of 25.56%, indicating efficient use of shareholders' equity to generate profits, which is a positive sign for potential investors.
  • The company has a market capitalization of approximately $29.99 billion, positioning it as a major player in the medical research sector, which could lead to further growth opportunities.

Agilent Technologies
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Agilent Technologies, Inc. for these reasons:

  • Barclays recently lowered its target price for Agilent Technologies, Inc. from $138.00 to $115.00, indicating a potential decrease in expected stock performance.
  • Insider selling has been observed, with executives selling shares, which may raise concerns about their confidence in the company's future performance.
  • The stock has a relatively high price-to-earnings (P/E) ratio of 24.18, which could suggest that it is overvalued compared to its earnings, making it a riskier investment.
  • Recent fluctuations in stock price, with a 12-month high of $155.35 and a low of $96.43, indicate volatility that could deter risk-averse investors.
  • Analysts have mixed ratings, with seven holding a "buy" rating and seven a "hold" rating, reflecting uncertainty in the stock's future trajectory.

A Forecast - Frequently Asked Questions

According to the research reports of 13 Wall Street equities research analysts, the average twelve-month stock price forecast for Agilent Technologies is $144.58, with a high forecast of $165.00 and a low forecast of $115.00.

13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Agilent Technologies in the last twelve months. There are currently 7 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" A shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in A, but not buy additional shares or sell existing shares.

According to analysts, Agilent Technologies's stock has a predicted upside of 41.22% based on their 12-month stock forecasts.

Over the previous 90 days, Agilent Technologies's stock had 1 upgrade by analysts.

Agilent Technologies has been rated by research analysts at Barclays, Robert W. Baird, TD Cowen, and Wells Fargo & Company in the past 90 days.

Analysts like Agilent Technologies less than other "medical" companies. The consensus rating for Agilent Technologies is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how A compares to other companies.


This page (NYSE:A) was last updated on 4/20/2025 by MarketBeat.com Staff
From Our Partners